BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

316 hedge funds and large institutions have $5.99B invested in Blueprint Medicines in 2024 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 140 increasing their positions, 83 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
316
Holders Change
+12
Holders Change %
+3.95%
% of All Funds
4.57%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
54
Increased
140
Reduced
83
Closed
40
Calls
$218M
Puts
$124M
Net Calls
+$94M
Net Calls Change
-$60.9M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$367M
2
BlackRock
2
BlackRock
New York
$659M
3
State Street
3
State Street
Massachusetts
$256M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$45.9M
5
ClearBridge Investments
5
ClearBridge Investments
New York
$44.6M

Top Sellers

1
RSCM
1
Rock Springs Capital Management
Maryland
$71.1M
2
Holocene Advisors
2
Holocene Advisors
New York
$1.56M
3
1832 Asset Management
3
1832 Asset Management
Ontario, Canada
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$498M
Name Holding Trade Value Shares
Change 		Shares
Change %
VFA
351
Virtus Fund Advisers
Connecticut
– -$15.8K -147 Closed
MIM
352
Macroview Investment Management
Maryland
– -$7.55K -70 Closed
IUHSA
353
Itau Unibanco Holding S.A.
Brazil
– -$5.39K -50 Closed
SC
354
Stephens Consulting
Michigan
– -$3.56K -33 Closed
IC
355
Innealta Capital
Texas
– -$647 -6 Closed
11 12 13 14
15